Skip to main navigation menu Skip to main content Skip to site footer
Academia Open

Medicine

Vol 9 No 2 (2024): December

Toxoplasma Infection Alters Lipid Profiles Challenging Cardiovascular Norms
Infeksi Toksoplasma Mengubah Profil Lipid yang Menantang Norma Kardiovaskular



(*) Corresponding Author
DOI
https://doi.org/10.21070/acopen.9.2024.9103
Published
June 7, 2024

Abstract

This study conducted at Baquba Teaching Hospital from January to April 2024, investigated the lipid profiles of 75 participants (50 patients with Toxoplasma and 25 controls) aged between 50 and 60 years. Existing research suggests a potential link between Toxoplasma infection and alterations in lipid metabolism; however, specific effects on different lipid fractions are not well-understood. This study aimed to explore the association between Toxoplasma infection and changes in lipid profiles, particularly focusing on whether infection status correlates with variations in high-density lipoprotein (HDL) levels. Venous blood samples were collected pre-breakfast and processed to obtain serum, which was analyzed for lipid profiles. The findings indicated that lipid levels generally increased in Toxoplasma patients compared to controls, except for a decrease in HDL levels. These results suggest that Toxoplasma infection could influence lipid metabolism, potentially impacting cardiovascular risk. Further research is needed to understand the mechanisms underlying these changes and their clinical implications.

Highlights:

  • Toxoplasma infection is linked to significant changes in lipid profiles.
  • The study identifies a unique decrease in HDL levels among infected individuals.
  • Implications suggest potential cardiovascular risks associated with Toxoplasma.

Keywords: Toxoplasma, Lipid Metabolism, Cardiovascular Risk, HDL Decrease

References

  1. J. P. Dubey and C. P. Beattie, "Toxoplasmosis of Animals and Man," CRC, Boca Raton, FL, 1988.
  2. S. A. Hosseini, A. Amouei, M. Sharif, S. Sarvi, L. Galal, J. Javidnia, A. S. Pagheh, S. Gholami, A. Mizani, and A. Daryani, "Human Toxoplasmosis: A Systematic Review for Genetic Diversity of Toxoplasma Gondii in Clinical Samples," Epidemiology & Infection, vol. 147, 2019.
  3. T. N. Chegeni, S. Sarvi, M. Moosazadeh, M. Sharif, S. A. Aghayan, A. Amouei, Z. Hosseininejad, and A. Daryani, "Is Toxoplasma Gondii a Potential Risk Factor for Alzheimer's Disease? A Systematic Review and Meta-Analysis," Microbial Pathogenesis, vol. 137, 103751, 2019.
  4. D. Anvari, M. Sharif, S. Sarvi, S. A. Aghayan, S. Gholami, A. S. Pagheh, S. A. Hosseini, R. Saberi, T. N. Chegeni, Z. Hosseininejad, and A. Daryani, "Seroprevalence of Toxoplasma Gondii Infection in Cancer Patients: A Systematic Review and Meta-Analysis," Microbial Pathogenesis, vol. 129, pp. 30-42, 2019.
  5. Jg, M., and O. Liesenfeld, "Toxoplasmosis," Lancet, vol. 363, no. 9425, pp. 1965-76, 2004.
  6. M. Siponen, P. M. Kinnunen, J. Koort, H. Kallio-Kokko, O. Vapalahti, A. M. Virtala, and P. Jokelainen, "Toxoplasma Gondii Seroprevalence in Veterinarians in Finland: Older Age, Living in the Countryside, Tasting Beef During Cooking and Not Doing Small Animal Practice Associated with Seropositivity," Zoonoses and Public Health, vol. 66, no. 2, pp. 207-215, 2019.
  7. M. M. Assim and E. J. Saheb, "The Association of Severe Toxoplasmosis and Some Cytokine Levels in Breast Cancer Patients," Iraqi Journal of Science, pp. 1189-1194, 2018.
  8. R. H. Nafal, H. S. Al-Warid, and H. J. Al-Sultan, "Seroprevalence of Toxoplasmosis in Patients with Chronic Liver Disease in Baghdad," Iraqi Journal of Science, pp. 1667-1672, 2019.
  9. L. R. Portugal, L. R. Fernandes, V. S. P. Pedroso, H. C. Santiago, R. T. Gazzinelli, and J. I. Alvarez-Leite, "Influence of Low-Density Lipoprotein (LDL) Receptor on Lipid Composition, Inflammation, and Parasitism During Toxoplasma Gondii Infection," Microbes and Infection, vol. 10, no. 3, pp. 276-284, 2008.
  10. C. Bisanz, O. Bastien, D. Grando, J. Jouhet, E. Maréchal, and M. F. Cesbron-Delauw, "Toxoplasma Gondii Acyl-Lipid Metabolism: De Novo Synthesis from Apicoplast-Generated Fatty Acids Versus Scavenging of Host Cell Precursors," Biochemical Journal, vol. 394, no. 1, pp. 197-205, 2006.
  11. D. Bansal, H. S. Bhatti, and R. Sehgal, "Role of Cholesterol in Parasitic Infections," Lipids in Health and Disease, vol. 4, no. 1, p. 10, 2005.
  12. A. Poznyak, A. V. Grechko, P. Poggio, V. A. Myasoedova, V. Alfieri, and A. N. Orekhov, "The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation," International Journal of Molecular Sciences, vol. 21, no. 5, 2020.
  13. A. Lambertini, A. Zannoni, N. Romagnoli, et al., "Expression of Proteinase-Activated Receptor 2 During Colon Volvulus in the Horse," Frontiers in Veterinary Science, vol. 7, pp. 589-670, 2020.
  14. M. R. Abess, M. K. Hussain, and Z. M. A. Jeddoa, "Lipid Profile and Coronary Heart Disease," Human Journals, vol. 11, no. 1, pp. 188-194, 2017.

Downloads

Download data is not yet available.